tiprankstipranks
Supernus Pharmaceuticals (DE:S49)
FRANKFURT:S49
Germany Market
S49
Supernus Pharmaceuticals
RESEARCH TOOLSreports

Supernus Pharmaceuticals (S49) Ratios

0 Followers

Supernus Pharmaceuticals Ratios

DE:S49's free cash flow for Q2 2026 was $0.85. For the 2026 fiscal year, DE:S49's free cash flow was decreased by $ and operating cash flow was $-0.25. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.08 1.90 2.35 1.70 1.07
Quick Ratio
 1.84 1.66 2.16 1.43 0.93
Cash Ratio
 0.52 0.38 0.24 0.26 0.14
Solvency Ratio
 -0.02 0.14 0.46 0.24 0.18
Operating Cash Flow Ratio
 0.06 0.14 0.59 0.38 0.17
Short-Term Operating Cash Flow Coverage
 1.85 0.00 0.00 0.00 0.29
Net Current Asset Value
$ 326.61M$ 253.25M$ 353.73M$ 136.96M$ -82.15M
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.03 0.03 0.26
Debt-to-Equity Ratio
 0.04 0.04 0.03 0.05 0.50
Debt-to-Capital Ratio
 0.04 0.04 0.03 0.04 0.33
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.38 1.37 1.32 1.39 1.92
Debt Service Coverage Ratio
 -0.18 0.00 0.00 36.68 0.37
Interest Coverage Ratio
 -48.30 0.00 0.00 -2.18 6.52
Debt to Market Cap
 <0.01 0.00 0.00 0.00 0.21
Interest Debt Per Share
 0.73 0.73 0.62 0.81 8.42
Net Debt to EBITDA
 8.81 -2.06 -0.20 -0.37 2.29
Profitability Margins
Gross Profit Margin
88.07%89.63%88.23%86.21%86.93%
EBIT Margin
-14.16%-6.82%14.79%0.85%10.16%
EBITDA Margin
-1.91%5.92%26.94%14.82%22.98%
Operating Profit Margin
-13.46%-5.13%12.34%-0.87%6.91%
Pretax Profit Margin
-14.87%-6.82%14.79%0.46%9.10%
Net Profit Margin
-13.23%-5.36%11.16%0.22%9.10%
Continuous Operations Profit Margin
-13.23%-5.36%11.16%0.22%9.10%
Net Income Per EBT
89.00%78.63%75.47%47.53%99.95%
EBT Per EBIT
110.42%133.00%119.84%-52.55%131.69%
Return on Assets (ROA)
-7.69%-2.65%5.40%0.10%3.57%
Return on Equity (ROE)
-10.42%-3.63%7.13%0.14%6.85%
Return on Capital Employed (ROCE)
-10.35%-3.31%7.59%-0.53%4.55%
Return on Invested Capital (ROIC)
-9.12%-2.58%5.69%-0.25%3.24%
Return on Tangible Assets
-13.09%-5.08%10.13%0.23%6.88%
Earnings Yield
-4.46%-1.37%3.71%0.08%3.17%
Efficiency Ratios
Receivables Turnover
 3.92 3.83 4.66 4.21 4.03
Payables Turnover
 17.71 27.85 16.98 42.66 8.27
Inventory Turnover
 1.18 0.91 1.43 1.08 0.95
Fixed Asset Turnover
 23.31 68.27 57.32 44.90 43.98
Asset Turnover
 0.58 0.49 0.48 0.48 0.39
Working Capital Turnover Ratio
 2.26 2.06 2.22 4.88 4.01
Cash Conversion Cycle
 381.73 485.53 311.24 415.30 429.49
Days of Sales Outstanding
 93.03 95.34 78.36 86.61 90.53
Days of Inventory Outstanding
 309.32 403.30 254.37 337.24 383.08
Days of Payables Outstanding
 20.61 13.10 21.49 8.56 44.12
Operating Cycle
 402.35 498.64 332.73 423.85 473.61
Cash Flow Ratios
Operating Cash Flow Per Share
 0.34 0.84 3.12 2.04 2.18
Free Cash Flow Per Share
 0.32 0.81 3.11 2.03 2.17
CapEx Per Share
 0.02 0.02 0.01 0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.94 0.97 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 17.71 35.37 237.17 201.61 283.56
Capital Expenditure Coverage Ratio
 17.71 35.37 237.17 201.61 283.56
Operating Cash Flow Coverage Ratio
 0.50 1.16 5.02 2.68 0.26
Operating Cash Flow to Sales Ratio
 0.02 0.07 0.26 0.18 0.18
Free Cash Flow Yield
0.76%1.64%8.59%7.00%6.08%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -22.08 -73.09 26.99 1.20K 31.53
Price-to-Sales (P/S) Ratio
 2.97 3.90 3.01 2.60 2.87
Price-to-Book (P/B) Ratio
 2.39 2.64 1.92 1.71 2.16
Price-to-Free Cash Flow (P/FCF) Ratio
 131.08 61.00 11.64 14.28 16.44
Price-to-Operating Cash Flow Ratio
 123.75 59.28 11.59 14.21 16.39
Price-to-Earnings Growth (PEG) Ratio
 0.21 0.48 <0.01 -12.25 2.65
Price-to-Fair Value
 2.39 2.64 1.92 1.71 2.16
Enterprise Value Multiple
 -146.39 63.91 10.98 17.16 14.78
Enterprise Value
 2.32B 2.72B 1.96B 1.54B 2.27B
EV to EBITDA
 -146.39 63.91 10.98 17.16 14.78
EV to Sales
 2.80 3.78 2.96 2.54 3.40
EV to Free Cash Flow
 123.64 59.10 11.43 13.98 19.46
EV to Operating Cash Flow
 116.66 57.43 11.38 13.91 19.40
Tangible Book Value Per Share
 7.62 6.51 7.20 3.75 1.24
Shareholders’ Equity Per Share
 17.76 18.81 18.80 16.90 16.51
Tax and Other Ratios
Effective Tax Rate
 0.11 0.21 0.25 0.52 <0.01
Revenue Per Share
 14.30 12.74 12.01 11.14 12.43
Net Income Per Share
 -1.89 -0.68 1.34 0.02 1.13
Tax Burden
 0.89 0.79 0.75 0.48 1.00
Interest Burden
 1.05 1.00 1.00 0.53 0.90
Research & Development to Revenue
 0.15 0.15 0.16 0.15 0.11
SG&A to Revenue
 0.68 0.68 0.51 0.39 0.16
Stock-Based Compensation to Revenue
 0.07 0.05 0.04 0.04 0.03
Income Quality
 -0.14 -1.23 2.33 84.41 1.92
Currency in USD